Sadeghi S, Goodarzi A. Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective. Dermatol Pract Concept [Internet]. 2022 Oct. 31 [cited 2026 Apr. 19];12(4):e2022178. Available from: https://mail.dpcj.org/index.php/dpc/article/view/2201